1. Executive Summary 2. United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025) 3. United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025) 4. United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025) 5. United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025 5.1 United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025 5.2 United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025 6. Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market 6.1 Market Drivers 6.2 Market Inhibitors 7. United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025 7.1 Prevnar / Prevnar 13 7.2 Pneumovax 23 7.3 Menactra 7.4 Bexsero 7.5 Menveo 7.6 Trumenba 8. United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis 9. United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies & Regulatory System 9.1 Reimbursement Policies 9.2 Regulation System 10. Promising Pneumococcal & Meningococcal Vaccines in Clinical Development 11. Major Deals in the Vaccines Market 11.1 Merger & Acquisitions 11.2 Collaboration Deals 11.3 Licensing Agreement 11.4 Exclusive Agreement 11.5 Distribution Agreement 11.6 Partnerships 12. Key Companies Analysis 12.1 Sanofi Pasteur 12.1.1 Business Overview 12.1.2 Vaccines Portfolio 12.1.3 Recent Development 12.2 GlaxoSmithKline (GSK) 12.2.1 Business Overview 12.2.2 Vaccines Portfolio 12.2.3 Recent Development 12.3 Merck 12.3.1 Business Overview 12.3.2 Vaccines Portfolio 12.3.3 Recent Development 12.4 Pfizer 12.4.1 Business Overview 12.4.2 Vaccines Portfolio 12.4.3 Recent Development

List of Tables Table 5–1: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018 Table 5–2: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025 Table 5–3: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2015 – 2018 Table 5–4: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025 Table 5–5: United States Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018 Table 5–6: United States Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025 Table 8–1: United States Pneumococcal & Meningococcal Adult Vaccines Price, 2019 – 2020 Table 8–2: United States Pneumococcal & Meningococcal Pediatric Vaccines Price, 2019 – 2020 Table 9–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization Table 11–1: Merger & Acquisitions in the Vaccines Market Table 11–2: Collaboration Deal in the Vaccines Market Table 11–3: Licensing Agreement in the Vaccines Market Table 11–4: Exclusive Agreement in the Vaccines Market Table 11–5: Distribution Agreement in the Vaccines Market Table 6–6: Partnerships in the Vaccines Market List of Figures Figure 2–1: United States Pneumococcal & Meningococcal Vaccines Market Size(Million US$),2015 – 2018 Figure 2–2: United States Pneumococcal & Meningococcal Vaccines Market Size Forecast(Million US$),2019 – 2025 Figure 3–1: United States Pneumococcal Vaccines Market Size (Million US$),2015 – 2018 Figure 3–2: United States Pneumococcal Vaccines Market Size Forecast (Million US$),2019 – 2025 Figure 4–1: United States Meningococcal Vaccines Market Size (Million US$),2015 – 2018 Figure 4–2: United States Meningococcal Vaccines Market Size Forecast (Million US$),2019 – 2025 Figure 7–1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 – 2018 Figure 7–2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025 Figure 7–3: United States Pneumovax 23 Market Value (Million US$),2015 – 2018 Figure 7–4: United States Pneumovax 23 Market Value Forecast (Million US$),2019 – 2025 Figure 7–5: United States Menactra Market Value (Million US$),2015 – 2018 Figure 7–6: United States Menactra Market Value Forecast (Million US$),2019 – 2025 Figure 7–7: United States Bexsero Market Value (Million US$),2015 – 2018 Figure 7–8: United States Bexsero Market Value Forecast (Million US$),2019 – 2025 Figure 7–9: United States Menveo Market Value (Million US$),2015 – 2018 Figure 7–10: United States Menveo Market Value Forecast (Million US$),2019 – 2025 Figure 7–11: United States Trumenba Market Value (Million US$),2017 – 2018 Figure 7–12: United States Trumenba Market Value Forecast (Million US$),2019 – 2025

Sanofi Pasteur, GlaxoSmithKline (GSK), Merck, Pfizer